BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32646926)

  • 21. Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study.
    Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Banerjea A; Humes DJ
    Br J Gen Pract; 2023 Nov; 73(736):e843-e849. PubMed ID: 37845084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
    Westwood M; Lang S; Armstrong N; van Turenhout S; Cubiella J; Stirk L; Ramos IC; Luyendijk M; Zaim R; Kleijnen J; Fraser CG
    BMC Med; 2017 Oct; 15(1):189. PubMed ID: 29061126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of 13,466 Fecal Immunochemical Tests in Patients Attending Primary Care for High- and Low-Risk Gastrointestinal Symptoms of Colorectal Cancer.
    Cama R; Kapoor N; Sawyer P; Patel B; Landy J
    Dig Dis Sci; 2023 May; 68(5):2023-2029. PubMed ID: 36357596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal immunochemical testing (FIT): sources of result variation based on three years of routine testing of symptomatic patients in English primary care.
    James T; Nicholson BD; Marr R; Paddon M; East JE; Justice S; Oke JL; Shine B
    Br J Biomed Sci; 2021 Oct; 78(4):211-217. PubMed ID: 33627037
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
    Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
    Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
    Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal immunochemical tests for occult blood testing should not be used outside of bowel screening: an audit of a large general practice.
    Byun UH; Anderson N; Upton A; Frankish P
    J Prim Health Care; 2019 Sep; 11(3):259-264. PubMed ID: 32171379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 33. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
    Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
    Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
    D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
    Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy.
    Kearsey CC; Graham C; Lobb HS; Chacko J; Weatherburn R; Rooney PS
    BMC Fam Pract; 2021 May; 22(1):90. PubMed ID: 33980161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England.
    Hunt N; Rao C; Logan R; Chandrabalan V; Oakey J; Ainsworth C; Smith N; Banerjee S; Myers M
    BMJ Open; 2022 Apr; 12(4):e059940. PubMed ID: 35418441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
    Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
    Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
    Farrugia A; Widlak M; Evans C; Smith SC; Arasaradnam R
    Frontline Gastroenterol; 2020 Jan; 11(1):28-33. PubMed ID: 31885837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.